Uniquely Adaptive and Controllable Cell Therapies
Our Platform
The ARC-SparX platform technology is a novel therapeutic approach in development for the treatment of cancer and autoimmune diseases.
The two-part ARC-SparX platform separates the disease recognition and killing functions of conventional cell therapies, enabling improved control of cell activity and precise targeting of antigens on diseased cells.
News
Join the Arcellx Team
Arcellx invites inquiries from candidates who share the vision of developing innovative immune cell therapies.